يعرض 1 - 20 نتائج من 156 نتيجة بحث عن '"colistimethate sodium"', وقت الاستعلام: 0.54s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    المساهمون: This publication is supported by ALPHARMA LLC company., Статья опубликована при финансовой поддержке Общества с ограниченной ответственностью «АЛФАРМА».

    المصدر: PULMONOLOGIYA; Том 33, № 4 (2023); 510-516 ; Пульмонология; Том 33, № 4 (2023); 510-516 ; 2541-9617 ; 0869-0189

    وصف الملف: application/pdf

    Relation: https://journal.pulmonology.ru/pulm/article/view/4307/3555; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4307/2061; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4307/2062; Worlitzsch D., Tarran R., Ulrich M. et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 2002; 109 (3): 317–325. DOI:10.1172/JCI0213870.; Кондратьева Е.И., Красовская С.А., Старинова М.А. и др., ред. Регистр пациентов с муковисцидозом в Российской Федерации. 2020 год. М.: Медпрактика-М; 2022. Доступно на: https://api.med-gen.ru/site/assets/files/51107/site_registre_2020.pdf; Rutter W.C., Burgess D.R., Burgess D.S. Increasing incidence of multidrug resistance among cystic fibrosis respiratory bacterial isolates. Microb. Drug Resist. 2017; 23 (1): 51–55. DOI:10.1089/mdr.2016.0048.; Cystic Fibrosis Foundation. Patient Registry 2021 Annual Data Report. Bethesda, Maryland; 2022. Available at: https://www.cff.org/sites/default/files/2021-11/Patient-Registry-Annual-Data-Report.pdf; Döring G., Flume P., Heijerman H. et al. Consensus study G. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J. Cyst. Fibros. 2012; 11 (6): 461–479. DOI:10.1016/j.jcf.2012.10.004.; Ryan C., Ross S., Davey P. et al. Prevalence and causes of prescribing errors: the PRescribing outcomes for trainee doctors engaged in clinical training (PROTECT) study. PLoS One. 2014; 9 (1): e79802. DOI:10.1371/journal.pone.0079802.; Mogayzel P.J., Naurckas E.T., Robinson K.A. et al. Cystic fibrosis foundation pulmonary guideline: pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann. Am. Thorac. Soc. 2010; 11 (10): 1640–1650. DOI:10.1513/AnnalsATS.201404-166OC.; Koerner-Rettberg C., Ballmann M. Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy. Core Evid. 2014; 9: 99–112. DOI:10.2147/CE.S64980.; Evans M.E., Feola D.J., Rapp R.P. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 1999; 33 (9): 960–967. DOI:10.1345/aph.18426.; Rogers M.J., Cohen J. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium. Infection. 1986; 14 (2): 79–81. DOI:10.1007/BF01644448.; Gaibani P., Lombardo D., Lewis R.E. et al. In vitro activity and postantibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates. J. Antimicrob. Chemother. 2014; 69 (7): 1856–1865. DOI:10.1093/jac/dku065.; Biswas S., Brunel J.M., Dubus .J.C. et al. Colistin: an update on the antibiotic of the 21st century. Expert Rev. Anti Infect. Ther. 2012; 10 (8): 917–934. DOI:10.1586/eri.12.78.; Taccetti G., Francalanci M., Pizzamiglio G. et al. Cystic fibrosis: recent insights into inhaled antibiotic treatment and future perspectives. Antibiotics (Basel). 2021; 10 (3): 338. DOI:10.3390/antibiotics10030338.; Alkhoury R., Kinkar E., Nokhbeh R., Saleh M.T. Monotherapy versus combination therapy for the treatment of Pseudomonas aeruginosa in cystic fibrosis patients. J. Antibiot. Res. 2018; 2 (1): 105. DOI:10.15744/2574-5980.2.105.; Ratjen F., Moeller A., McKinney M.L. et al. Eradication of early P. aeruginosa infection in children < 7years of age with cystic fibrosis: the early study. J. Cyst. Fibros. 2019; 18 (1): 78–85. DOI:10.1016/j.jcf.2018.04.002.; Министерство здравоохранения Российской Федерации. Кистозный фиброз (муковисцидоз): клинические рекомендации. 2021. Доступно на: https://cr.minzdrav.gov.ru/schema/372_2; Министерство здравоохранения Российской Федерации. Приказ № 835н «Об утверждении стандарта медицинской помощи детям при кистозном фиброзе (муковисцидозе) (диагностика, лечение и диспансерное наблюдение)». 2021. Доступно на: https://docs.cntd.ru/document/608494977; https://journal.pulmonology.ru/pulm/article/view/4307

  11. 11
    Academic Journal
  12. 12
  13. 13
  14. 14
    Academic Journal

    المصدر: MICROORGANISMS ; ISSN: 2076-2607

    وصف الملف: application/pdf

  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
  18. 18
  19. 19
    Academic Journal
  20. 20
    Academic Journal